http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105209031-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c145c7d784bb48e170c102f2587e99ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e8cc3701ed4c4f042a7b88ebff70203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_162cacf0d591b432412c89437dea28e0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D203-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
filingDate 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb4adce7dbb0b67b17c38096ac9bf0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e131582e5e2063a61a2c446785b7bef1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b38ba690c160b44083d937b823fbbd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d4764df38f3f1f8b165592489126eaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa90240ee40b7945d83d99ed02cdf8f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88725a1637b0a3b6eab1d27cb50a58d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79d497cd0225c556e4f3163a99a480b5
publicationDate 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105209031-A
titleOfInvention Novel antiviral agents against HBV infection
abstract The present invention relates to novel compounds of formula (I) as nucleocapsid assembly inhibitors for the treatment of viruses, including especially but not exclusively for the treatment of hepatitis B virus (HBV) and novel methods of using said compounds Inhibitors of HBV pregenomic RNA encapsidation in infection and related pathologies. (Formula (I)) includes its hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes, wherein A, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are defined herein.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109069488-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019206072-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111393391-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111393391-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111349056-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111349056-B
priorityDate 2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466884931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID301571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466113214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467250516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467680204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415930893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468086256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467986257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467434171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467503999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467228232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415774157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467545602

Total number of triples: 86.